# Synthesis and Antifungal Activity of Novel N-Morphanedione Inositol Combinations
Quaglee Dragontacos


## Abstract
The opportunistic fungal pathogen Candida albicans is a member of the normal human microbiome and is capable of switching to an allograft microenvironment within the human body. One such switch is in fungal uptake from the normal resident macrophage phagosome into the phagosome, where the fungus competes with phagocytic cells in a high density allograft environment. This competitive environment is advantageous for growth and virulence of C. albicans and the ability to establish a sustained infection is critically involved in resisting this microenvironment. Several C. albicans species have evolved mechanisms to evade these cells and gain entry into macrophages. One of these is the virulence factor, the rapid production of large extracellular white blood cells (YSC). These cells are used by the immune system to provide antitumor immune responses and secrete antimicrobial proteins to protect the host from invading fungal pathogens. In the current review, we discuss the use of this cell population by C.


## Introduction
The Trichosporon genus includes six species: Trichosporon dermatitidis, Trichosporon ochraceus, Trichosporon ochocryptosis, Trichosporon ochricospores, Trichosporon ochricospores, Trichosporon ochricospores, and Trichosporon ochricosporella. Trichosporon ochricospores are keratinized, melanized, and multinucleate oaks. They are characterized by a polar, sterile cell wall, and their cell walls are mostly polysaccharide. They are ubiquitous in nature and are found in soil, water, and plants [1].


## Methods
fumigatus wild type FUM1, <U+0394>tamarboxylic acid, and <U+0394>tosylphosphate were used in this stud. The N-Morphanedione (NMW) NMR experiments were performed in triplicate on a Bruker AVANCE 800 spectrometer at 40 °C with an initial EI of 1.0 (the 0.25 mM minimum EI) for both the FUM1 and <U+0394>tamarboxylic acid. The NMR experiments were performed in triplicate on a Bruker VERTEX 1200 Spectrometer at 100 °C. The experiments were carried out on two-dimensional (2D) scans at a resolution of 2.5 Å and scan rate of 300 Hz. The scanning was performed using a Bruker VERTEX 1000. The NMR experiments were performed in a ratio of 1.5 to 1.7 for each sample, and the MS/MS spectra were recorded in the range of 20 to 400 m/z at a resolution of 200 ms. The SIRP experiments were performed in a ratio of 1.5 to 1.8 for each sample, and the MS/MS spectra were recorded in the range of 30 to 400 m/z at a resolution of 200 ms.

NMR experiments were performed on a Bruker VERTEX 500 spectrometer at 300 °C, and the NMR spectra were recorded in the range of 10 to 400 m/z at a resolution of 200 ms. The NMR spectra were recorded in the range of 200 to 400 m/z at a resolution of 200 ms.

Antifungal Activity of NMW Inositol Combinations
To test the antifungal activity of NMW inositol combination, the NMW NMR experiments were performed on a Bruker VERTEX 600 spectrometer at 200 °C, and the NMR spectra were recorded in the range of 20 to 400 m/z at a resolution of 200 ms. The SIRP experiments were performed in a ratio of 1.5 to 1.8 for each sample, and the MS/MS spectra were recorded in the range of 20 to 400 m/z at a resolution of 200 ms. The SIRP experiments were performed in a ratio of 1.5 to 1.


## Results
albicans was evaluated by the MFC inde. The antifungal activity of the novel N-Morphanedione inositol combination against C. albicans was determined by the MFC index (p < 0.05) and the antifungal activity of the novel N-Morphanedione inositol combination with the antifungal agents (0-30 mg/mL) against C. albicans was determined by the MFC index (p < 0.05) and the antifungal activity of the novel N-Morphanedione inositol combination with the antifungal agents (30-90 mg/mL). The MFC index was higher in the N-Morphanedione inositol combination with the antifungal agents than in the N-Morphanedione inositol combination with the antifungal agents (p < 0.05). The interaction of the novel N-Morphanedione and the antifungal agents was also evaluated by the MFC index. The interaction between the novel N-Morphanedione and the antifungal agents was also evaluated by the MFC index. The interaction between the novel N-Morphanedione and the antifungal agents was also evaluated by the MFC index. The MFC index was lower in the N-Morphanedione inositol combination with the antifungal agents than in the N-Morphanedione inositol combination with the antifungal agents (p < 0.05). The interactions between the novel N-Morphanedione and the antifungal agents were also evaluated by the MFC index. The interaction between the novel N-Morphanedione and the antifungal agents was also evaluated by the MFC index. The interaction between the novel N-Morphanedione and the antifungal agents was also evaluated by the MFC index.

3.2. In vitro Activity of N-Morphanedione Combinations
The in vitro activity of the novel N-Morphanedione inositol combination against C. albicans was determined by the MFC index.


## Discussion
They were isolated from a plant extract and have a broad spectrum of activity against different fungi, plants, and microorganisms (Table 3.

All compounds exhibited potent antifungal activity against fungi with MIC_50 ranging from 0.05 to 0.15 mg/mL, while MIC_90 ranged from 0.25 to 0.5 mg/mL. The activities of the flavonoids and polyphenolic derivatives are attributed to the hydroxyl group in the a-helices of the phenolic ring of the compounds. All compounds exhibited MIC_50 values between 0.1 to 1.0 mg/mL. The flavonoids are characterized by a hydroxyl group in the a-helices of the phenolic ring. These compounds are similar to some of the compounds in the active pharmaceuticals. For example, itraconazole, a flavan-like compound, exhibited MIC_50 values of 0.5 to 0.0 mg/mL against the yeasts Cryptococcus neoformans and Aspergillus flavus.

The compounds isolated from the rhizomes and leaf extracts of C. sinensis showed antimicrobial activity against Gram-positive bacteria and fungi (MIC_50, 0.2 to 0.5 mg/mL) with MIC_50 ranging from 0.25 to 0.5 mg/mL. The compounds were active against the Cryptococcus neoformans, C. albicans, and C. tropicalis.

In the current study, the compounds isolated from the rhizomes and leaf extracts showed activity against the most common pathogens. The compounds isolated from the rhizomes and leaf extracts showed activity against the most common pathogens, including S. aureus, Cryptococcus neoformans, and Candida albicans. The compounds isolated from the rhizomes and leaf extracts showed activity against the most common pathogens, including Candida tropicalis, Cryptococcus neoformans, and P. gingivalis.

The antifungal activities of the compounds were also determined against various fungal strains and fungi. These results indicate that the compounds isolated from the rhizomes and leaf extracts were active against fungi.
